EPISODE · Oct 25, 2024 · 45 MIN
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
from Oncology Today with Dr Neil Love
Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.
Embed this episode
NOW PLAYING
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
0:00
45:46
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Today with Dr Neil Love?
This episode is 45 minutes long.
When was this Oncology Today with Dr Neil Love episode published?
This episode was published on October 25, 2024.
Can I download this Oncology Today with Dr Neil Love episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!